Literature DB >> 27206526

P2X7 nucleotide receptor signaling potentiates the Wnt/β-catenin pathway in cells of the osteoblast lineage.

Matthew W Grol1,2, Patricia J Brooks3,4, Alexey Pereverzev5, S Jeffrey Dixon6,7,8.   

Abstract

The P2X7 and Wnt/β-catenin signaling pathways regulate osteoblast differentiation and are critical for the anabolic responses of bone to mechanical loading. However, whether these pathways interact to control osteoblast activity is unknown. The purpose of this study was to investigate the effects of P2X7 activation on Wnt/β-catenin signaling in osteoblasts. Using MC3T3-E1 cells, we found that combined treatment with Wnt3a and the P2X7 agonist 2'(3')-O-(4-benzoylbenzoyl)adenosine 5'-triphosphate (BzATP) elicited more sustained β-catenin nuclear localization than that induced by Wnt3a alone. Wnt3a-induced increases in β-catenin transcriptional activity were also potentiated by treatment with BzATP. Consistent with involvement of P2X7, a high ATP concentration (1 mM) potentiated Wnt3a-induced β-catenin transcriptional activity, whereas a low concentration (10 μM) of ATP, adenosine 5'-diphosphate (ADP), or uridine 5'-triphosphate (UTP) failed to elicit a response. The potentiation of β-catenin transcriptional activity elicited by BzATP was also inhibited by two distinct P2X7 antagonists: A 438079 and A 740003. Furthermore, responses to Wnt3a in calvarial cells isolated from P2rx7 knockout mice were significantly less than in cells from wild-type controls. In MC3T3-E1 cells, BzATP increased inhibitory phosphorylation of glycogen synthase kinase 3β (GSK3β), a process that was blocked by A 438079 and diminished by inhibition of protein kinase C. Thus, P2X7 signaling may potentiate the canonical Wnt pathway through GSK3β inhibition. Taken together, we show that P2X7 activation prolongs and potentiates Wnt/β-catenin signaling. Consequently, cross-talk between P2X7 and Wnt/β-catenin pathways may modulate osteoblast activity in response to mechanical loading.

Entities:  

Keywords:  Glycogen synthase kinase 3β; Osteoblast; P2X7 receptors; Wnt; β-catenin

Mesh:

Substances:

Year:  2016        PMID: 27206526      PMCID: PMC5023632          DOI: 10.1007/s11302-016-9517-4

Source DB:  PubMed          Journal:  Purinergic Signal        ISSN: 1573-9538            Impact factor:   3.765


  42 in total

1.  Targeted overexpression of Dkk1 in osteoblasts reduces bone mass but does not impair the anabolic response to intermittent PTH treatment in mice.

Authors:  Gang-Qing Yao; Jian-Jun Wu; Nancy Troiano; Karl Insogna
Journal:  J Bone Miner Metab       Date:  2010-07-03       Impact factor: 2.626

Review 2.  Biomechanical and molecular regulation of bone remodeling.

Authors:  Alexander G Robling; Alesha B Castillo; Charles H Turner
Journal:  Annu Rev Biomed Eng       Date:  2006       Impact factor: 9.590

3.  The Wnt co-receptor LRP5 is essential for skeletal mechanotransduction but not for the anabolic bone response to parathyroid hormone treatment.

Authors:  Kimihiko Sawakami; Alexander G Robling; Minrong Ai; Nathaniel D Pitner; Dawei Liu; Stuart J Warden; Jiliang Li; Peter Maye; David W Rowe; Randall L Duncan; Matthew L Warman; Charles H Turner
Journal:  J Biol Chem       Date:  2006-06-20       Impact factor: 5.157

4.  P2X7 nucleotide receptor is coupled to GSK-3 inhibition and neuroprotection in cerebellar granule neurons.

Authors:  Felipe Ortega; Raquel Pérez-Sen; Esmerilda G Delicado; M Teresa Miras-Portugal
Journal:  Neurotox Res       Date:  2009-02-24       Impact factor: 3.911

Review 5.  Purinergic signalling and bone remodelling.

Authors:  Isabel R Orriss; Geoffrey Burnstock; Timothy R Arnett
Journal:  Curr Opin Pharmacol       Date:  2010-02-25       Impact factor: 5.547

6.  Chronic elevation of parathyroid hormone in mice reduces expression of sclerostin by osteocytes: a novel mechanism for hormonal control of osteoblastogenesis.

Authors:  T Bellido; A A Ali; I Gubrij; L I Plotkin; Q Fu; C A O'Brien; S C Manolagas; R L Jilka
Journal:  Endocrinology       Date:  2005-08-04       Impact factor: 4.736

Review 7.  Purine and pyrimidine receptors.

Authors:  G Burnstock
Journal:  Cell Mol Life Sci       Date:  2007-06       Impact factor: 9.261

8.  PTH/cAMP/PKA signaling facilitates canonical Wnt signaling via inactivation of glycogen synthase kinase-3beta in osteoblastic Saos-2 cells.

Authors:  Akira Suzuki; Keiichi Ozono; Takuo Kubota; Hiroki Kondou; Kanako Tachikawa; Toshimi Michigami
Journal:  J Cell Biochem       Date:  2008-05-01       Impact factor: 4.429

9.  Inactivation of Lrp5 in osteocytes reduces young's modulus and responsiveness to the mechanical loading.

Authors:  Liming Zhao; Joon W Shim; Todd R Dodge; Alexander G Robling; Hiroki Yokota
Journal:  Bone       Date:  2013-01-26       Impact factor: 4.398

10.  P2X7-induced zeiosis promotes osteogenic differentiation and mineralization of postmenopausal bone marrow-derived mesenchymal stem cells.

Authors:  José Bernardo Noronha-Matos; João Coimbra; Ana Sá-e-Sousa; Rui Rocha; José Marinhas; Rolando Freitas; Sónia Guerra-Gomes; Fátima Ferreirinha; Maria Adelina Costa; Paulo Correia-de-Sá
Journal:  FASEB J       Date:  2014-08-28       Impact factor: 5.191

View more
  7 in total

Review 1.  The potential of P2X7 receptors as a therapeutic target, including inflammation and tumour progression.

Authors:  Geoffrey Burnstock; Gillian E Knight
Journal:  Purinergic Signal       Date:  2017-11-21       Impact factor: 3.765

Review 2.  Small Molecules Enhance Scaffold-Based Bone Grafts via Purinergic Receptor Signaling in Stem Cells.

Authors:  Patrick Frank Ottensmeyer; Markus Witzler; Margit Schulze; Edda Tobiasch
Journal:  Int J Mol Sci       Date:  2018-11-14       Impact factor: 5.923

3.  Highly-expressed P2X7 receptor promotes growth and metastasis of human HOS/MNNG osteosarcoma cells via PI3K/Akt/GSK3β/β-catenin and mTOR/HIF1α/VEGF signaling.

Authors:  Yingchi Zhang; Hao Cheng; Wenkai Li; Hua Wu; Yong Yang
Journal:  Int J Cancer       Date:  2019-03-18       Impact factor: 7.396

4.  High glucose inhibits osteogenic differentiation and proliferation of MC3T3‑E1 cells by regulating P2X7.

Authors:  Jinsan Yang; Cao Ma; Maoshu Zhang
Journal:  Mol Med Rep       Date:  2019-10-31       Impact factor: 2.952

Review 5.  From purines to purinergic signalling: molecular functions and human diseases.

Authors:  Zhao Huang; Na Xie; Peter Illes; Francesco Di Virgilio; Henning Ulrich; Alexey Semyanov; Alexei Verkhratsky; Beata Sperlagh; Shu-Guang Yu; Canhua Huang; Yong Tang
Journal:  Signal Transduct Target Ther       Date:  2021-04-28

6.  Modeling Interactions among Individual P2 Receptors to Explain Complex Response Patterns over a Wide Range of ATP Concentrations.

Authors:  Shu Xing; Matthew W Grol; Peter H Grutter; S Jeffrey Dixon; Svetlana V Komarova
Journal:  Front Physiol       Date:  2016-07-13       Impact factor: 4.566

7.  Calcium sensing receptor protects high glucose-induced energy metabolism disorder via blocking gp78-ubiquitin proteasome pathway.

Authors:  Yuehong Wang; Ping Gao; Can Wei; Hongzhu Li; Li Zhang; Yajun Zhao; Bo Wu; Ye Tian; Weihua Zhang; Lingyun Wu; Rui Wang; Changqing Xu
Journal:  Cell Death Dis       Date:  2017-05-18       Impact factor: 8.469

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.